| Detection of High-Risk HPV in Urine and Cervical Swab Specimen Using HPV Diagnostic Kit (Bio Farma) (NCT06111911) | PT Bio Farma | 2022-04-01 |
| Reducing Abundance of Human Papilloma Virus in Women by Taking Probiotic (NCT05316064) | Universiti Sains Malaysia | 2021-12-27 |
| Papilocare®: Effects on Regression of Histologically Confirmed Cervical Intraepithelial Lesions 1 and Tolerance (NCT04624568) | Centre Hospitalier Régional d'Orléans | 2020-11-17 |
| A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine (NCT05694728) | Beijing Health Guard Biotechnology, Inc | 2020-05-23 |
| Developing Methods to Investigate Additional Opportunities of HPV Vaccination by Using First-void Urine Samples (NCT04391647) | Universiteit Antwerpen | 2020-05-11 |
| Prevalence of HPV-associated Eye Infection and Cytokine Levels in Tears From Patients Diagnosed With Pterygium (NCT04117386) | Chulalongkorn University | 2020-01-01 |
| Clinical Trial to Explore Papilocare Gel Efficacy to Repair of the Cervico-vaginal Mucosa With HPV High Risk Lesions. (NCT04199078) | Procare Health Iberia S.L. | 2019-09-25 |
| Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection (NCT03677960) | Antiva Biosciences | 2018-12-17 |
| Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection (NCT03202992) | Antiva Biosciences | 2017-08-11 |
| The HPV Self-test as a Test of Cure in Madagascar (NCT02811367) | University Hospital, Geneva | 2016-06-01 |
| Community-Driven Cervical Cancer Prevention in Western Kenya (NCT02124252) | Duke University | 2016-01-01 |
| Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine (AB-SOP Study) (NCT02714114) | Universiteit Antwerpen | 2015-09-01 |
| Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions (NCT02135419) | AIDS Malignancy Consortium | 2014-09-24 |
| Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer (NCT01898494) | ECOG-ACRIN Cancer Research Group | 2014-01-22 |
| Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer (NCT02048020) | Jonsson Comprehensive Cancer Center | 2013-12-26 |
| Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV (NCT01946139) | AIDS Malignancy Consortium | 2013-12-04 |
| Increasing Human Papillomavirus Vaccine Uptake in Low-Income, Ethnic Minority Adolescents in Los Angeles County (NCT02067507) | University of California, Los Angeles | 2012-06-01 |
| Clinical Evaluation of the APTIMA® HPV Assay Using the PANTHER™ System (NCT01446198) | Gen-Probe, Incorporated | 2012-03-01 |
| Hybrid Capture Test on Mobile Unit Program to Improve Cervical Cancer Screening in Brazilian Rural and Remote Areas (NCT01539668) | Barretos Cancer Hospital | 2012-03-01 |
| The Parents in Appalachia Receive Education Needed for Teen Project (NCT01901770) | Ohio State University Comprehensive Cancer Center | 2012-01-01 |
| Post-Licensure Study of the Safety of GARDASIL™ in Males (V501-070) (NCT01567813) | Merck Sharp & Dohme LLC | 2011-06-23 |
| Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens (NCT02634190) | Hologic Deutschland GmbH | 2009-06-01 |
| Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia (NCT00303823) | National Cancer Institute (NCI) | 2005-09-01 |
| Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia (NCT00054041) | National Cancer Institute (NCI) | 2004-06-01 |